• Publications
  • Influence
10-Year Outcomes After Roux-en-Y Gastric Bypass
Objective(s): The aim of the study was to evaluate the clinical effectiveness and long-term durability of Roux-en-Y Gastric Bypass (RYGB) at an accredited center. Background: Short-term data haveExpand
  • 80
  • 1
10-Year outcomes after Roux-en-Y gastric bypass
  • 29
  • 1
Increased Glucose Variability Is Associated With Major Adverse Events After Coronary Artery Bypass.
BACKGROUND Elevated preoperative hemoglobin A1c (HbA1c) is a predictor of poor outcomes following coronary artery bypass grafting (CABG), but the role of postoperative glucose variability (GV) isExpand
  • 5
Predictors of new persistent opioid use after coronary artery bypass grafting.
OBJECTIVE Deaths from prescription opioid overdose have quadrupled in the past 15 years, and no studies have evaluated appropriate opioid prescribing after cardiac surgery. The aim of this study isExpand
  • 5
Persistent Opioid Use After Open Aortic Surgery: Risk Factors, Costs and Consequences.
BACKGROUND The incidence and financial impact of persistent opioid use (POU) after open aortic surgery is undefined. METHODS Insurance claim data from opioid-naïve patients who underwent aorticExpand
  • 1
Increased glucose variability is associated with atrial fibrillation after coronary artery bypass
Elevated preoperative hemoglobin A1c (HbA1c) is a predictor of poor outcomes following coronary artery bypass grafting (CABG), but the role of increased postoperative glucose variability (GV) isExpand
  • 2
New Persistent Opioid Use After Aortic and Mitral Valve Surgery in Commercially Insured Patients.
BACKGROUND Deaths from prescription opioid overdose are dramatically increasing. This study evaluates the incidence, risk factors, and cost of new persistent opioid use after aortic valve replacementExpand
  • 1